mNextSpike

Drug

Related News

Moderna Reports Q4 Revenue Beat Amid Cost Cuts and Regulatory Setback

Feb 17, 2026

Moderna posted Q4 2025 revenue of $678 million, beating analyst estimates despite a 29.8% year-over-year decline. The company reduced operating expenses by 31% while facing FDA refusal to file its flu vaccine application.

Moderna Reports Q4 2025 Results, Cuts Costs 30% Amid FDA Flu Vaccine Setback

Feb 13, 2026

Moderna reported Q4 2025 revenue of $700 million and full-year revenue of $1.9 billion, beating estimates while cutting operating expenses by $2.2 billion. The FDA refused to file the company's seasonal flu vaccine application.